Target Price | $142.80 |
Price | $136.10 |
Potential |
4.92%
register free of charge
|
Number of Estimates | 20 |
20 Analysts have issued a price target Insmed Incorporated 2026 .
The average Insmed Incorporated target price is $142.80.
This is
4.92%
register free of charge
$252.00
85.16%
register free of charge
$99.99
26.53%
register free of charge
|
|
A rating was issued by 25 analysts: 24 Analysts recommend Insmed Incorporated to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Insmed Incorporated stock has an average upside potential 2026 of
4.92%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 363.71 | 481.79 |
19.17% | 32.47% | |
EBITDA Margin | -214.87% | -205.26% |
2.97% | 4.47% | |
Net Margin | -251.24% | -245.19% |
2.30% | 2.41% |
21 Analysts have issued a sales forecast Insmed Incorporated 2025 . The average Insmed Incorporated sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Insmed Incorporated EBITDA forecast 2025. The average Insmed Incorporated EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Insmed Incorporated Analysts have issued a net profit forecast 2025. The average Insmed Incorporated net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -5.57 | -5.60 |
4.31% | 0.54% | |
P/E | negative | |
EV/Sales | 57.03 |
22 Analysts have issued a Insmed Incorporated forecast for earnings per share. The average Insmed Incorporated EPS is
This results in the following potential growth metrics and future valuations:
Insmed Incorporated...
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 21 2025 |
William Blair |
Locked
➜
Locked
|
Locked | Aug 20 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Aug 20 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
Mizuho |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
Analyst Rating | Date |
---|---|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 21 2025 |
Locked
William Blair:
Locked
➜
Locked
|
Aug 20 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 20 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Aug 14 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 14 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 13 2025 |
Locked
Mizuho:
Locked
➜
Locked
|
Aug 13 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.